Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Ermenegildo Zegna NV
ZGN
DexCom
DXCM
Workday
WDAY
(Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -8.22%3.05B | 16.59%4.52B | 16.59%4.52B | -11.45%2.99B | 0.39%3.06B | 28.26%3.32B | 52.47%3.87B | 52.47%3.87B | 104.09%3.38B | 83.37%3.05B |
-Cash and cash equivalents | -8.22%3.05B | 16.59%4.52B | 16.59%4.52B | -11.45%2.99B | 0.39%3.06B | 28.26%3.32B | 52.47%3.87B | 52.47%3.87B | 104.09%3.38B | 83.37%3.05B |
Receivables | -3.94%377.8M | -1.29%421.4M | -1.29%421.4M | 7.37%431M | 18.94%427.7M | -0.13%393.3M | 0.90%426.9M | 0.90%426.9M | 10.27%401.4M | 9.53%359.6M |
-Other receivables | -3.94%377.8M | -1.29%421.4M | -1.29%421.4M | 7.37%431M | 18.94%427.7M | -0.13%393.3M | 0.90%426.9M | 0.90%426.9M | 10.27%401.4M | 9.53%359.6M |
Inventory | 8.44%26.08B | 11.31%24.9B | 11.31%24.9B | 11.11%25.54B | 10.05%24.84B | 7.15%24.05B | 3.31%22.37B | 3.31%22.37B | 5.92%22.98B | 13.73%22.57B |
Prepaid assets | 20.83%121.8M | 26.77%117.9M | 26.77%117.9M | 65.75%96.3M | 18.05%98.1M | 14.42%100.8M | 20.16%93M | 20.16%93M | -37.59%58.1M | 7.64%83.1M |
Restricted cash | 5.90%2.27B | 22.45%2.31B | 22.45%2.31B | 22.93%2.17B | 16.43%1.99B | 26.50%2.15B | 9.78%1.89B | 9.78%1.89B | 6.53%1.77B | 16.51%1.71B |
Total current assets | 5.11%33.7B | 11.46%34.75B | 11.46%34.75B | 8.81%33.81B | 10.68%33.09B | 10.55%32.06B | 8.24%31.17B | 8.24%31.17B | 12.76%31.07B | 16.67%29.9B |
Non current assets | ||||||||||
Net PPE | 15.70%50.1M | 8.36%70M | 8.36%70M | 1,186.71%571.3M | 1,112.90%526.4M | -7.08%43.3M | -55.26%64.6M | -55.26%64.6M | 3.98%44.4M | 4.08%43.4M |
-Gross PPE | 15.70%50.1M | 8.36%70M | 8.36%70M | 1,186.71%571.3M | 1,112.90%526.4M | -7.08%43.3M | -55.26%64.6M | -55.26%64.6M | 3.98%44.4M | 4.08%43.4M |
Goodwill and other intangible assets | -64.66%173.9M | -2.98%169.4M | -2.98%169.4M | -1.79%489.4M | 0.39%489.3M | 170.09%492.1M | 0.29%174.6M | 0.29%174.6M | 17.25%498.3M | 189.26%487.4M |
-Goodwill | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M | 0.00%163.5M |
-Other intangible assets | -96.84%10.4M | -46.85%5.9M | -46.85%5.9M | -2.66%325.9M | 0.59%325.8M | 1,657.22%328.6M | 4.72%11.1M | 4.72%11.1M | 28.03%334.8M | 6,378.00%323.9M |
Financial assets | -38.22%60.3M | -69.66%47.3M | -69.66%47.3M | -43.31%50M | 0.14%69.5M | 80.74%97.6M | -58.75%155.9M | -58.75%155.9M | -47.72%88.2M | -69.56%69.4M |
Non current deferred assets | -27.57%127.4M | -10.52%167.5M | -10.52%167.5M | 28.57%156.6M | 48.26%166.5M | 27.56%175.9M | 32.67%187.2M | 32.67%187.2M | -22.62%121.8M | -14.73%112.3M |
Other non current assets | 911.48%396.5M | -2.03%391.8M | -2.03%391.8M | 2.13%76.6M | 10.55%56.6M | -88.62%39.2M | 17.96%399.9M | 17.96%399.9M | 82.04%75M | -9.70%51.2M |
Total non current assets | 0.66%1.33B | -3.63%1.36B | -3.63%1.36B | 7.25%1.34B | 2.75%1.31B | 4.47%1.32B | -9.08%1.41B | -9.08%1.41B | -4.81%1.25B | 20.05%1.27B |
Total assets | 4.94%35.03B | 10.81%36.1B | 10.81%36.1B | 8.75%35.15B | 10.35%34.4B | 10.30%33.38B | 7.35%32.58B | 7.35%32.58B | 11.96%32.32B | 16.81%31.17B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -8.42%1.67B | -6.35%1.45B | -6.35%1.45B | -0.56%1.53B | -7.47%1.5B | 10.77%1.83B | 1.17%1.55B | 1.17%1.55B | -22.83%1.54B | 8.11%1.62B |
-accounts payable | 8.91%1.37B | 7.97%1.35B | 7.97%1.35B | 3.15%1.41B | 10.80%1.39B | 4.59%1.26B | -8.39%1.25B | -8.39%1.25B | -9.14%1.37B | -9.23%1.25B |
-Total tax payable | -46.95%300.7M | -65.25%105.3M | -65.25%105.3M | -30.08%120.4M | -70.13%109M | 27.54%566.8M | 77.19%303M | 77.19%303M | -64.89%172.2M | 213.76%364.9M |
Current accrued expenses | 25.10%481M | 25.52%486M | 25.52%486M | 14.39%425.3M | 6.58%406.5M | -1.18%384.5M | -11.48%387.2M | -11.48%387.2M | 8.55%371.8M | 9.10%381.4M |
Current deferred liabilities | -40.77%72.5M | -32.22%99.7M | -32.22%99.7M | -20.83%136.8M | -13.23%148.9M | -25.14%122.4M | -34.39%147.1M | -34.39%147.1M | -38.26%172.8M | -39.45%171.6M |
Current liabilities | -4.59%2.23B | -2.26%2.04B | -2.26%2.04B | 0.43%2.1B | -5.45%2.05B | 5.99%2.33B | -4.99%2.08B | -4.99%2.08B | -20.38%2.09B | 1.94%2.17B |
Non current liabilities | ||||||||||
Long term provisions | 12.12%1.51B | 10.59%1.52B | 10.59%1.52B | 14.66%1.48B | 12.14%1.39B | 11.04%1.35B | 15.88%1.37B | 15.88%1.37B | 16.58%1.29B | 21.28%1.24B |
Long term debt and capital lease obligation | -3.47%5.15B | 16.11%5.97B | 16.11%5.97B | -6.65%5.74B | -0.44%5.99B | -7.03%5.33B | -15.90%5.14B | -15.90%5.14B | 2.19%6.15B | 7.10%6.01B |
-Long term debt | -3.64%5.1B | 16.16%5.92B | 16.16%5.92B | -6.79%5.69B | -0.49%5.94B | -7.03%5.29B | -16.03%5.09B | -16.03%5.09B | 2.18%6.11B | 7.13%5.97B |
-Long term capital lease obligation | 17.53%52.3M | 10.81%53.3M | 10.81%53.3M | 12.04%51.2M | 5.59%47.2M | -7.10%44.5M | 0.42%48.1M | 0.42%48.1M | 3.86%45.7M | 3.47%44.7M |
Employee benefits | 7.42%505.2M | 7.29%569.7M | 7.29%569.7M | 8.02%525.3M | 15.96%539.7M | 13.49%470.3M | 1.28%531M | 1.28%531M | 6.53%486.3M | -0.19%465.4M |
Derivative product liabilities | -66.47%57.2M | -62.61%63M | -62.61%63M | -76.67%20.6M | -79.55%6.3M | 426.54%170.6M | -61.42%168.5M | -61.42%168.5M | -23.08%88.3M | -87.06%30.8M |
Other non current liabilities | -3.20%118.1M | -16.53%123.2M | -16.53%123.2M | -0.43%138.7M | -2.40%125.9M | 8.35%122M | 30.27%147.6M | 30.27%147.6M | 18.55%139.3M | 32.85%129M |
Total non current liabilities | -1.40%7.34B | 11.99%8.24B | 11.99%8.24B | -3.05%7.91B | 2.17%8.05B | -0.88%7.44B | -12.08%7.36B | -12.08%7.36B | 4.35%8.15B | 5.92%7.88B |
Total liabilities | -2.16%9.57B | 8.85%10.28B | 8.85%10.28B | -2.34%10B | 0.53%10.1B | 0.68%9.78B | -10.61%9.44B | -10.61%9.44B | -1.86%10.24B | 5.03%10.05B |
Shareholders'equity | ||||||||||
Share capital | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M |
-common stock | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M | 0.00%4M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 17.31%28.67B | 18.49%27.95B | 18.49%27.95B | 20.76%26.77B | 21.97%25.51B | 21.83%24.44B | 22.96%23.59B | 22.96%23.59B | 25.71%22.16B | 30.20%20.91B |
Paid-in capital | 1.98%3.51B | 1.70%3.49B | 1.70%3.49B | 1.89%3.46B | 2.19%3.43B | 2.63%3.44B | 2.47%3.43B | 2.47%3.43B | 2.32%3.39B | 2.11%3.36B |
Less: Treasury stock | 53.04%7.24B | 41.64%6.13B | 41.64%6.13B | 42.62%5.57B | 43.96%5.13B | 45.01%4.73B | 37.78%4.33B | 37.78%4.33B | 35.14%3.91B | 38.09%3.56B |
Total stockholders'equity | 7.73%24.94B | 11.53%25.31B | 11.53%25.31B | 13.85%24.66B | 14.98%23.82B | 14.89%23.15B | 17.01%22.7B | 17.01%22.7B | 19.90%21.66B | 23.47%20.71B |
Noncontrolling interests | 15.31%519M | 15.83%511.6M | 15.83%511.6M | 16.04%494.2M | 17.55%480.9M | 12.78%450.1M | 13.46%441.7M | 13.46%441.7M | 14.18%425.9M | 19.31%409.1M |
Total equity | 7.88%25.46B | 11.61%25.82B | 11.61%25.82B | 13.90%25.15B | 15.03%24.3B | 14.85%23.6B | 16.94%23.14B | 16.94%23.14B | 19.78%22.08B | 23.39%21.12B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |